Shifts in treatment initiation patterns among newly diagnosed multiple sclerosis patients in Germany: a claims data analysis from 2017 to 2022

One of the key insights from this claims‑data study is the changing “time‑to‑therapy” clock for newly diagnosed MS patients in Germany. Early starts are climbing in some groups, while others see mounting delays - especially those with progressive onset. Dive in to uncover what’s driving the shift and why timing now matters more than ever.

By Stratil A‑S, Papukchieva S, Joschko N, Meuth SG, & Friedrich B. in Sage Journal, ISSN 1756‑2856 (print) / eISSN 1756‑2864 (online).